Annual Congress Munich 2006

Saturday, 02.09.2006
Sunday, 03.09.2006
Monday, 04.09.2006
Tuesday, 05.09.2006
Wednesday, 06.09.2006

Citations should be made in the following way: Authors. Title. Eur Respir J 2006; 28: Suppl. 50, abstract number.

Material from 2006:

4395 Abstracts
610 Slide presentations
175 Webcasts
95 Handouts
175 Multimedia files

Material from 2006: Show

Clinical aspects and treatment of lower respiratory infection in COPD patients

Oral Presentation
Chairs: T. Wilkinson (Essex, United Kingdom), P. Van Der Valk (Enschede, Netherlands)

Download all media

Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD A. Marin, M. Garcia, N. Amatria, R. Hervas, G. Bonet, I. Badorrey, J. Morera, E. Monso (Badalona, Spain)
Early recurrent exacerbation and exacerbation therapy G. C. Donaldson, R. Baghai, W. Perera, T. M. A. Wilkinson, J. A. Wedzicha (London, United Kingdom)
Isolated or time-clustered exacerbations have similar impacts on hospitalization rates and quality of life G. C. Donaldson, R. Baghai, W. Perera, T. M. A. Wilkinson, J. A. Wedzicha (London, United Kingdom)
*Genomic variability of haemophilus* in patients with COPD** M. Garcia-Nunez, N. Amatria, A. Marian, I. Badorrey, G. Bonet, M. Sabria, J. Morera, E. Monso (Barcelona, Spain)
*Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae* (NTHi) infection of COPD lung tissue** D. Droemann, J. Rupp, T. Goldmann, F. Xu, J. Deiwick, P. Zabel, K. Dalhoff (Borstel, Luebeck, Germany)
Placebo-controlled, double-blind trial of chronic, intermittent ‘pulse‘ therapy of moxifloxacin to prevent acute exacerbations in COPD patients with chronic bronchitis: baseline data S. Sethi, A. Anzueto, R. Wilson, P. W. Jones, J. A. Wedzicha, M. Miravitlles, A. Kureshi, P. Sagnier, J. Russell, M. Schmitt, P. Arvis, B. Hampel (United States Of America; United Kingdom; Spain; China; France; South Africa; Germany)
Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with acute exacerbations of chronic bronchitis (AECB) in PROTEKT years 1–5 (1999–2004) D. J. Farrell, J. Liñares (London, United Kingdom; Barcelona, Spain)
Greatest International ANti-infective Trial (GIANT) – the German cohort: moxifloxacin treatment provides short- and long-term benefits in AECB patients M. Miravitlles, S. Ewig, D. Legnani, A. Anzueto, H. Landen, K. Stauch (Barcelona, Spain; Bochum, Wuppertal, Germany; Milan, Italy; San Antonio, United States Of America)